2.要約中間連結財務諸表及び主な注記
(1)要約中間連結純損益及びその他の包括利益計算書
| | (単位:百万円) |
| 前中間連結会計期間 (自 2024年4月1日 至 2024年9月30日) | 当中間連結会計期間 (自 2025年4月1日 至 2025年9月30日) |
売上収益 | 146,404 | 137,879 |
売上原価 | △63,507 | △60,679 |
売上総利益 | 82,897 | 77,200 |
販売費及び一般管理費 | △42,214 | △42,516 |
研究開発費 | △10,944 | △12,371 |
製品に係る無形資産償却費 | △4,505 | △4,446 |
その他の収益 | 207 | 417 |
その他の費用 | △1,568 | △369 |
営業利益 | 23,873 | 17,915 |
金融収益 | 1,008 | 884 |
金融費用 | △1,043 | △1,164 |
税引前中間利益 | 23,839 | 17,634 |
法人所得税費用 | △5,135 | △3,780 |
中間利益 | 18,704 | 13,854 |
その他の包括利益 | | |
純損益に振り替えられない項目: | | |
その他の包括利益を通じて公正価値で測定する金融資産の純変動 | △1,287 | 380 |
純損益に振り替えられる可能性のある項目: | | |
在外営業活動体の換算差額 | △4,259 | 7,855 |
キャッシュ・フロー・ヘッジ | 10 | - |
持分法適用会社におけるその他の包括利益に対する持分 | △148 | - |
その他の包括利益 | △5,683 | 8,235 |
中間包括利益合計 | 13,020 | 22,089 |
中間利益の帰属 | | |
親会社の所有者持分 | 18,772 | 13,940 |
非支配持分 | △68 | △86 |
中間利益 | 18,704 | 13,854 |
中間包括利益合計の帰属 | | |
親会社の所有者持分 | 13,058 | 22,188 |
非支配持分 | △38 | △99 |
中間包括利益合計 | 13,020 | 22,089 |
1株当たり中間利益 | | |
基本的1株当たり中間利益(円) | 52.88 | 41.76 |
希薄化後1株当たり中間利益(円) | 52.74 | 41.70 |
<コアベース>
E0094945360参天製薬株式会社SANTEN PHARMACEUTICAL CO., LTD.四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2025-04-012025-09-30HY2026-03-312024-04-012024-09-302025-03-311falsefalsefalse453602025-04-012025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-04-012025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-04-012025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-04-012025-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-09-30jpigp_cor:RetainedEarningsIFRSMember453602024-09-30jpigp_cor:TreasurySharesIFRSMember453602024-09-30jpigp_cor:CapitalSurplusIFRSMember453602024-09-30jpigp_cor:ShareCapitalIFRSMember453602024-04-012024-09-30jpigp_cor:NonControllingInterestsIFRSMember453602024-04-012024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-04-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-04-012024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-04-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-04-012024-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-04-012024-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-04-012024-09-30jpigp_cor:RetainedEarningsIFRSMember453602024-04-012024-09-30jpigp_cor:TreasurySharesIFRSMember453602024-04-012024-09-30jpigp_cor:CapitalSurplusIFRSMember453602024-04-012024-09-30jpigp_cor:ShareCapitalIFRSMember453602024-03-31jpigp_cor:NonControllingInterestsIFRSMember453602024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-03-31jpigp_cor:RetainedEarningsIFRSMember453602024-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-03-31jpigp_cor:TreasurySharesIFRSMember453602024-03-31jpigp_cor:CapitalSurplusIFRSMember453602024-03-31jpigp_cor:ShareCapitalIFRSMember453602025-09-30jpigp_cor:NonControllingInterestsIFRSMember453602025-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-09-30jpigp_cor:RetainedEarningsIFRSMember453602025-09-30jpigp_cor:TreasurySharesIFRSMember453602025-09-30jpigp_cor:CapitalSurplusIFRSMember453602025-09-30jpigp_cor:ShareCapitalIFRSMember453602025-04-012025-09-30jpigp_cor:NonControllingInterestsIFRSMember453602025-04-012025-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-03-31jpigp_cor:NonControllingInterestsIFRSMember453602025-04-012025-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-04-012025-09-30jpigp_cor:RetainedEarningsIFRSMember453602025-04-012025-09-30jpigp_cor:TreasurySharesIFRSMember453602025-04-012025-09-30jpigp_cor:CapitalSurplusIFRSMember453602025-04-012025-09-30jpigp_cor:ShareCapitalIFRSMember453602025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-03-31jpigp_cor:RetainedEarningsIFRSMember453602025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-03-31jpigp_cor:TreasurySharesIFRSMember453602025-03-31jpigp_cor:CapitalSurplusIFRSMember453602025-03-31jpigp_cor:ShareCapitalIFRSMember453602024-09-30jpigp_cor:NonControllingInterestsIFRSMember453602024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-04-012025-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-04-012024-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-11-06453602025-09-30453602025-03-31453602025-04-012025-09-30453602024-09-30453602024-04-012024-09-30453602024-03-31453602025-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602025-04-012025-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-04-012024-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602025-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure